Li Ka Shing Institute of Virology

The Li Ka Shing Institute of Virology (LKSIoV) unites a consortium of researchers to support discoveries in vaccines, treatments, and diagnostic tests for viral diseases affecting humans. Through leadership in scientific excellence & international collaboration, the Li Ka Shing Institute of Virology invests in virology and immunology research to discover new methods to prevent, treat, and cure vir

us-related disease to reduce the burden of viral disease around the world. The Institute builds on internationally recognized virology expertise and infrastructure with global connections to such partners as the US National Institutes of Health, the Bill and Melinda Gates Foundation and more. Lorne Tyrrell is the Founding Director of the Li Ka Shing Institute of Virology and a Distinguished University Professor at the University of Alberta. Dr. Tyrrell has received numerous prestigious awards for his studies on viral hepatitis. Since the COVID-19 pandemic, Dr. Tyrrell has worked on antivirals and vaccines for SARS-CoV-2. He is a member of the COVID-19 Vaccine Task Force that advises the Federal Government on the selection of COVID-19 vaccines based on efficacy, safety, and timely availability for Canada.